1. Australia Stocks

  2. •

    Healthcare

  3. •

    Medical - Care Facilities
Ceretas Limited

Ceretas Limited

CTS.AX
Ceretas LimitedAU flagAustralian Securities Exchange
0.89
AUD
+0.03
- -
68.36MMarket Cap
No data availableFinancial data will appear here once available

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Company Description

Company Profile APIChatGPT
CEO
Rachel de las Heras
Sector
Healthcare
Industry
Medical - Care Facilities
Address
348 Edward Street Brisbane QLD Australia 4000
IPO Date
Jul 23, 2026
Website
ceretas.com.au
Similar Companies
PT Nitrasanata Dharma Tbk (JECX.JK)
Kt Medical Service Public Company Limited (KTMS.BK)
Care Service Co.,Ltd. (2425.T)
AfroCentric Investment Corporation Limited (ACT.JO)
Healthia Limited (HLA.AX)
Assure Holdings Corp. (IONM)
Business
Ceretas Limited, a medical technology company that develops portable and non-invasive therapeutic ultrasound platform for the treatment of Alzheimer's disease and other neurodegenerative conditions in Australia. The company's technology operates through two primary mechanisms, including neuromodulation, which uses low-intensity focused ultrasound to stimulate neural circuits; and BBBO, which temporarily and reversibly opens the blood-brain barrier using ultrasound combined with circulating microbubbles that facilitates brain's natural clearance of amyloid-beta and tau and helps delivery of co-administered drugs to targeted brain regions. Ceretas Limited was incorporated in 2024 and is based in Brisbane, Australia.